Cargando…

Immune Checkpoint Inhibitor-Induced Diabetic Ketoacidosis: A Report of Four Cases and Literature Review

Immune checkpoint inhibitors (ICIs) have been widely used in the treatment of various types of cancers worldwide. Although ICI-related autoimmune diabetes is a rare complication, it can be associated with a life-threatening condition, diabetic ketoacidosis (DKA). Here, we report the cases of four pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, A Ram, Yoon, Jee Hee, Kim, Hee Kyung, Kang, Ho-Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997462/ https://www.ncbi.nlm.nih.gov/pubmed/32047478 http://dx.doi.org/10.3389/fendo.2020.00014

Ejemplares similares

Malignant Prolactinoma With Liver Metastases Masquerading as Metastatic Gastrointestinal Stromal Tumor: A Case Report and Literature Review
por: Hong, A Ram, et al.
Publicado: (2020)

MON-575 Clinical Implication of Sonographic Evaluation for Immune Checkpoint Inhibitor-Related Thyroiditis: A Case Series Study
por: Hong, A Ram, et al.
Publicado: (2019)

THU018 Remarkable Response Of ACTH-secreting Pituitary Carcinoma To Immune Checkpoint Inhibitors: A Case Report
por: Park, Ji Yong, et al.
Publicado: (2023)

Combined diabetic ketoacidosis and hyperosmolar hyperglycemic state in type 1 diabetes mellitus induced by immune checkpoint inhibitors: Underrecognized and underreported emergency in ICIs-DM
por: Zhang, Wenjing, et al.
Publicado: (2023)

Early Thyroid Volume Reduction in Subacute Thyroiditis Can be a Potential Indicator for Hypothyroidism
por: Park, Ji Yong, et al.
Publicado: (2022)

Characteristics of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1/PD-L1 Inhibitors
por: Yoon, Jee Hee, et al.
Publicado: (2021)

FRI138 Diagnostic Accuracy Of Plasma Renin Activity Measured By Radioimmunoassay And LC-MS/MS For The Screening Of Primary Aldosteronism
por: Hong, A Ram, et al.
Publicado: (2023)

Coexistence of Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes and Pancreatitis
por: Zhang, Amy L., et al.
Publicado: (2021)

Immune checkpoint inhibitor– and phosphatidylinositol-3-kinase inhibitor–related diabetes induced by antineoplastic drugs: two case reports and a literature review
por: Gao, Yue, et al.
Publicado: (2023)

Non-Occlusive Mesenteric Ischemia in Children With Diabetic Ketoacidosis: Case Report and Review of Literature
por: Frontino, Giulio, et al.
Publicado: (2022)

Diabetic Ketoacidosis Post Bariatric Surgery
por: Rizo, Ivania M., et al.
Publicado: (2019)

Insulin Allergy to Detemir Followed by Rapid Onset of Diabetic Ketoacidosis: A Case Report and Literature Review
por: Teo, Chong Boon, et al.
Publicado: (2022)

Immune checkpoint inhibitor-induced takotsubo syndrome and diabetic ketoacidosis: rare reactions
por: Oldfield, Kieran, et al.
Publicado: (2021)

Endocrine side effects of immune checkpoint inhibitors
por: Cardona, Zulma, et al.
Publicado: (2023)

Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task
por: Barnabei, Agnese, et al.
Publicado: (2022)

Case report: Diabetic muscle infarction with diabetic ketoacidosis: A rare complication of diabetes
por: Tang, Jun, et al.
Publicado: (2023)

Euglycemic Diabetic Ketoacidosis in the Setting of SGLT2 Inhibitor Use and Hypertriglyceridemia: A Case Report and Review of Literature
por: Gajjar, Kushani, et al.
Publicado: (2019)

Steroid-Induced Diabetic Ketoacidosis: A Case Report and Review of the Literature
por: Cavataio, Megan M, et al.
Publicado: (2022)

Real-world adherence to toxicity management guidelines for immune checkpoint inhibitor-induced diabetes mellitus
por: Shen, Min, et al.
Publicado: (2023)

Review of Evidence for Adult Diabetic Ketoacidosis Management Protocols
por: Tran, Tara T. T., et al.
Publicado: (2017)

Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus
por: Hilder, Robin, et al.
Publicado: (2023)

Thyroid-related adverse events induced by immune checkpoint inhibitors
por: Chera, Alexandra, et al.
Publicado: (2022)

Initial Potassium Replacement in Diabetic Ketoacidosis: The Unnoticed Area of Gap
por: Usman, Atif
Publicado: (2018)

Corrigendum: Review of Evidence for Adult Diabetic Ketoacidosis Management Protocols
por: Tran, Tara T. T., et al.
Publicado: (2017)

Uncovering the alarming rise of diabetic ketoacidosis during COVID-19 pandemic: a pioneer African study and review of literature
por: Gorchane, Asma, et al.
Publicado: (2023)

Mechanisms and therapeutic strategies of immune checkpoint molecules and regulators in type 1 diabetes
por: Ding, Jia-Tong, et al.
Publicado: (2023)

Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma
por: Changizzadeh, Pouyan N., et al.
Publicado: (2017)

Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?
por: Di Molfetta, Sergio, et al.
Publicado: (2021)

Editorial: Immune checkpoint inhibitors in cancer: balancing the benefits with the side effects?
por: Gomes-Lima, Cristiane J., et al.
Publicado: (2023)

Case Report: Occurrence of Thyroid Storm in a Young Patient With Recurrent Diabetic Ketoacidosis
por: Iino, Tatsuya, et al.
Publicado: (2022)

Free, bioavailable 25-hydroxyvitamin D levels and their association with diabetic ketoacidosis in children with type 1 diabetes at diagnosis
por: Choe, Yunsoo, et al.
Publicado: (2022)

An Unsuspected Case of Euglycemic Diabetic Ketoacidosis With Twists
por: Kang, Cyra-Yoonsun, et al.
Publicado: (2022)

Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside
por: Wu, Linda, et al.
Publicado: (2021)

Diabetic Ketoacidosis in an Euglycemic Patient
por: Mumtaz, Hassan, et al.
Publicado: (2020)

Alpelisib-Induced Diabetic Ketoacidosis
por: Nguyen, Paul, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors-Related Thyroid Dysfunction: Epidemiology, Clinical Presentation, Possible Pathogenesis, and Management
por: Zhan, Ling, et al.
Publicado: (2021)

Immune checkpoint inhibitor-induced hypothyroidism predicts treatment response in Japanese subjects
por: Iwamoto, Yuichiro, et al.
Publicado: (2023)

Sodium-glucose Cotransporter-2 Inhibitors and Euglycaemic Diabetic Ketoacidosis in the Perioperative Period: Case Report
por: Jhaveri, Urmita, et al.
Publicado: (2019)

Euglycemic Diabetic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor Use Post-Bariatric Surgery: A Brief Review of the Literature
por: Iqbal, Qasim Z, et al.
Publicado: (2020)

A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis
por: Patel, Khyati, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3ak5l4jqbgf08f95gpbaoij1vl